Focused on High Value Cells

Solentim launches new workflow for single cell cloning of stem cells

VIPS™ + MatriClone™ combination ensures high efficiency seeding of hiPSCs with high viability Solentim, the global leader for solutions to create, isolate and characterize the highest value cells for the development of new biological medicines, yesterday launched a dedicated new workflow for single cell cloning of human induced pluripotent stem cells (hiPSCs). A combination of Solentim’s VIPS™ (verified in-situ plate seeding) instrument …

Read more Solentim launches new workflow for single cell cloning of stem cells

Service and support: Service Status Certification for laboratory accreditation

The quality of a cell line development (CLD) process is dependent on the optimization of many discrete, measurable stages. When considering the optimization of instruments used in CLD workflows, using technology that is fit for purpose, installed, maintained, operated and functioning correctly, and used by staff who are trained correctly, all contribute to a quality …

Read more Service and support: Service Status Certification for laboratory accreditation

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Bournemouth, UK and Newark, CA, USA, 20th April 2020 / Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening …

Read more Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This agreement creates the most efficient cell line development solution for biotherapeutic drug developers yet, by integrating Solentim’s VIPS™ (verified in-situ plate seeding) hardware for isolating single …

Read more Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Technology facilitating single cell cloning to help meet regulatory requirements

Patricia Fitzpatrick Diamond discusses recent technological advances aiding single cell cloning, including Solentim’s VIPS™, in GEN. To meet regulatory standards, recombinant proteins must be produced from a single cell line, demonstrating monoclonality whilst maintaining viability. This is a slow and involved process, with commonly used methods exhibiting significant draw backs. Limiting dilution retains the viability …

Read more Technology facilitating single cell cloning to help meet regulatory requirements

Solentim completes strong final quarter of 2017 for product shipments

New VIPS single cell printer shipped to customers in US and Europe NEWS – Bournemouth, UK – 3rd January, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, has announced that they completed a very strong final quarter of 2017 for product shipments. Shipments included several units of the new VIPS single cell printers to customers …

Read more Solentim completes strong final quarter of 2017 for product shipments

Translate »